Tim1 and Tim3 are not essential for experimental allergic asthma

Clinical and Experimental Allergy

Volumn 41, Issue 7, 2011, Pages 1012-1021

  Barlow, J L ^a   Wong, S H ^b   Ballantyne, S J ^c   Jolin, H E ^a   Mckenzie, A N J ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b MEDIMMUNE   (United States)

^c UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Airway hyperreactivity; Asthma; Eosinophils; Tim1; Tim3; Type 2

Indexed keywords

CD86 ANTIGEN; KIDNEY INJURY MOLECULE 1; MUCIN; T CELL IMMUNOGLOBULIN MUCIN 3; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; EOSINOPHILIA; LUNG INFILTRATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD86; ASTHMA; B-LYMPHOCYTES; BRONCHIAL HYPERREACTIVITY; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INFLAMMATION; LUNG; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; RECEPTORS, VIRUS;

EID: 79958773665     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2011.03728.x     Document Type: Article

References (24)

1. Fallon PG, Jolin HE, Smith P et al. IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. Immunity 2002; 17:7-17.
2. Howard TD, Meyers DA, Bleecker ER. Mapping susceptibility genes for asthma and allergy. J Allergy Clin Immunol 2000; 105:S477-81.
3. McKenzie GJ, Fallon PG, Emson CL, Grencis RK, McKenzie AN. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J Exp Med 1999; 189:1565-72.
4. McMillan SJ, Bishop B, Townsend MJ, McKenzie AN, Lloyd CM. The absence of interleukin 9 does not affect the development of allergen-induced pulmonary inflammation nor airway hyperreactivity. J Exp Med 2002; 195:51-7.
5. Townsend JM, Fallon GP, Matthews JD, Smith P, Jolin EH, McKenzie NA. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 2000; 13:573-8.
6. Wills-Karp M, Luyimbazi J, Xu X et al. Interleukin-13: central mediator of allergic asthma. Science 1998; 282:2258-61.
7. McIntire JJ, Umetsu SE, Akbari O et al. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat Immunol 2001; 2:1109-16.
8. McIntire JJ, Umetsu SE, Macaubas C et al. Immunology: hepatitis A virus link to atopic disease. Nature 2003; 425:576.
9. Liu Q, Shang L, Li J et al. A functional polymorphism in the TIM-1 gene is associated with asthma in a Chinese Han population. Int ArchAllergy Immunol 2007; 144:197-202.
10. Graves PE, Siroux V, Guerra S, Klimecki WT, Martinez FD. Association of atopy and eczema with polymorphisms in T-cell immunoglobulin domain and mucin domain-IL-2-inducible T-cell kinase gene cluster in chromosome 5 q 33. J Allergy Clin Immunol 2005; 116:650-6.
11. Meyers JH, Chakravarti S, Schlesinger D et al. TIM-4 is the ligand for TIM-1, and the TIM-1-TIM-4 interaction regulates T cell proliferation. Nat Immunol 2005; 6:455-64.
12. Umetsu SE, Lee WL, McIntire JJ et al. TIM-1 induces T cell activation and inhibits the development of peripheral tolerance. Nat Immunol 2005; 6:447-54.
13. Encinas JA, Janssen EM, Weiner DB et al. Anti-T-cell Ig and mucin domain-containing protein 1 antibody decreases TH2 airway inflammation in a mouse model of asthma. J Allergy Clin Immunol 2005; 116:1343-9.
14. Sizing ID, Bailly V, McCoon P et al. Epitope-dependent effect of anti-murine TIM-1 monoclonal antibodies on T cell activity and lung immune responses. J Immunol 2007; 178:2249-61.
15. Xiao S, Najafian N, Reddy J et al. Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function. J Exp Med 2007; 204:1691-702.
16. Kearley J, McMillan SJ, Lloyd CM. Th2-driven, allergen-induced airway inflammation is reduced after treatment with anti-Tim-3 antibody in vivo. J Exp Med 2007; 204:1289-94.
17. Wong SH, Barlow JL, Nabarro S, Fallon PG, McKenzie AN. Tim-1 is induced on germinal centre B cells through B-cell receptor signalling but is not essential for the germinal centre response. Immunology 2010; 131:77-88.
18. Murphy E, Hieny S, Sher A, O'Garra A. Detection of in vivo expression of interleukin-10 using a semi-quantitative polymerase chain reaction method in Schistosoma mansoni infected mice. J Immunol Methods 1993; 162:211-23.
19. Ballantyne SJ, Barlow JL, Jolin HE et al. Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J Allergy Clin Immunol 2007; 120:1324-31.
20. Sanchez-Fueyo A, Tian J, Picarella D et al. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 2003; 4:1093-101.
21. Anderson AC, Anderson DE, Bregoli L et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 2007; 318:1141-3.
22. Rennert PD, Ichimura T, Sizing ID et al. T cell, Ig domain, mucin domain-2 gene-deficient mice reveal a novel mechanism for the regulation of Th2 immune responses and airway inflammation. J Immunol 2006; 177:4311-2.
23. Gao PS, Mathias RA, Plunkett B et al. Genetic variants of the T-cell immunoglobulin mucin 1 but not the T-cell immunoglobulin mucin 3 gene are associated with asthma in an African American population. J Allergy Clin Immunol 2005; 115:982-8.
24. Noguchi E, Nakayama J, Kamioka M, Ichikawa K, Shibasaki M, Arinami T. Insertion/deletion coding polymorphisms in hHAVcr-1 are not associated with atopic asthma in the Japanese population. Genes Immun 2003; 4:170-3.